JP2022519930A5 - - Google Patents
Info
- Publication number
- JP2022519930A5 JP2022519930A5 JP2021557396A JP2021557396A JP2022519930A5 JP 2022519930 A5 JP2022519930 A5 JP 2022519930A5 JP 2021557396 A JP2021557396 A JP 2021557396A JP 2021557396 A JP2021557396 A JP 2021557396A JP 2022519930 A5 JP2022519930 A5 JP 2022519930A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962825017P | 2019-03-27 | 2019-03-27 | |
| US62/825,017 | 2019-03-27 | ||
| PCT/US2020/025532 WO2020198705A1 (en) | 2019-03-27 | 2020-03-27 | Combinations useful in a method for treating sarcoma |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022519930A JP2022519930A (ja) | 2022-03-25 |
| JP2022519930A5 true JP2022519930A5 (https=) | 2023-04-04 |
| JPWO2020198705A5 JPWO2020198705A5 (https=) | 2023-04-04 |
| JP7602481B2 JP7602481B2 (ja) | 2024-12-18 |
Family
ID=72609016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557396A Active JP7602481B2 (ja) | 2019-03-27 | 2020-03-27 | 肉腫を治療する方法に有用な組み合わせ |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220152024A1 (https=) |
| EP (1) | EP3947379A4 (https=) |
| JP (1) | JP7602481B2 (https=) |
| CN (1) | CN114096537B (https=) |
| AU (1) | AU2020248103A1 (https=) |
| BR (1) | BR112021019170A2 (https=) |
| CA (1) | CA3134648A1 (https=) |
| EA (1) | EA202192349A1 (https=) |
| IL (1) | IL286647A (https=) |
| MX (1) | MX2021011688A (https=) |
| WO (1) | WO2020198705A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH593266A5 (https=) * | 1973-09-20 | 1977-11-30 | Delalande Sa | |
| AU2002228922A1 (en) * | 2000-12-12 | 2002-06-24 | Cytovia, Inc. | Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| AU2007335744A1 (en) * | 2006-12-20 | 2008-06-26 | Alberto A. Gabizon | Method for administration of pegylated liposomal doxorubicin |
| KR20220143164A (ko) * | 2012-11-21 | 2022-10-24 | 피티씨 테라퓨틱스, 인크. | 치환된 리버스 피리미딘 ｂｍｉ-1 저해제 |
| CN113164479A (zh) * | 2018-08-17 | 2021-07-23 | Ptc医疗公司 | 用于治疗胰腺癌的方法 |
| SG11202109503TA (en) * | 2019-03-11 | 2021-09-29 | Ptc Therapeutics Inc | Compound form having enhanced bioavailability and formulations thereof |
-
2020
- 2020-03-27 MX MX2021011688A patent/MX2021011688A/es unknown
- 2020-03-27 CA CA3134648A patent/CA3134648A1/en active Pending
- 2020-03-27 EP EP20776386.3A patent/EP3947379A4/en not_active Withdrawn
- 2020-03-27 CN CN202080039624.8A patent/CN114096537B/zh active Active
- 2020-03-27 WO PCT/US2020/025532 patent/WO2020198705A1/en not_active Ceased
- 2020-03-27 AU AU2020248103A patent/AU2020248103A1/en not_active Abandoned
- 2020-03-27 JP JP2021557396A patent/JP7602481B2/ja active Active
- 2020-03-27 US US17/441,355 patent/US20220152024A1/en not_active Abandoned
- 2020-03-27 BR BR112021019170A patent/BR112021019170A2/pt not_active Application Discontinuation
- 2020-03-27 EA EA202192349A patent/EA202192349A1/ru unknown
-
2021
- 2021-09-23 IL IL286647A patent/IL286647A/en unknown